InceptionR’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-512
Closed -$471K 801
2026
Q1
$471K Sell
512
-675
-57% -$684K 0.11% 332
2025
Q4
$1.28M Sell
1,187
-67
-5% -$64.1K 0.35% 55
2025
Q3
$957K Buy
1,254
+826
+193% +$615K 0.23% 138
2025
Q2
$334K Sell
428
-1,023
-71% -$795K 0.08% 422
2025
Q1
$1.2M Buy
1,451
+536
+59% +$446K 0.36% 70
2024
Q4
$706K Buy
915
+130
+17% +$108K 0.16% 252
2024
Q3
$695K Buy
+785
New +$706K 0.17% 235
2023
Q2
Sell
-3,529
Closed -$1.21M 540
2023
Q1
$1.21M Buy
+3,529
New +$1.19M 0.39% 63

Other funds holding LLY

InceptionR's LLY Position: Q2 2026 in Review

InceptionR sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 512 shares — an estimated $471K sold.

InceptionR first reported a position in LLY in Q1 2023 and held it in 8 quarters. The position peaked at $1.28M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • InceptionR reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • InceptionR sold 512 Eli Lilly shares in Q2 2026, an estimated $471K.
  • InceptionR first reported a position in Eli Lilly in Q1 2023 and held it in 8 quarters.
  • InceptionR's Eli Lilly position peaked at $1.28M in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.